IndyGeneUS AI Secures Pathogen Sequencing Capability to Support COVID-19 Genomic Surveillance Initiatives

This pathogen sequencing capacity has emerged at a pivotal moment in the efforts across the continent to enhance genomic surveillance and track COVID-19 variant strains. Yusuf Henriques, founder and CEO of IndyGeneUS, shared how critical this work is. “We must move quickly to address the threat that COVID-19 and its variants pose to the entire continent of Africa. Our partners understand this urgency and are all aligned to support this mission.”
Read more...

;